These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 8678922)
1. Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men. Zgliczynski S; Ossowski M; Slowinska-Srzednicka J; Brzezinska A; Zgliczynski W; Soszynski P; Chotkowska E; Srzednicki M; Sadowski Z Atherosclerosis; 1996 Mar; 121(1):35-43. PubMed ID: 8678922 [TBL] [Abstract][Full Text] [Related]
2. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system. Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481 [TBL] [Abstract][Full Text] [Related]
3. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men. Berg G; Schreier L; Geloso G; Otero P; Nagelberg A; Levalle O Horm Metab Res; 2002 Feb; 34(2):87-92. PubMed ID: 11972293 [TBL] [Abstract][Full Text] [Related]
4. Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men. Jockenhövel F; Bullmann C; Schubert M; Vogel E; Reinhardt W; Reinwein D; Müller-Wieland D; Krone W Metabolism; 1999 May; 48(5):590-6. PubMed ID: 10337859 [TBL] [Abstract][Full Text] [Related]
5. Effect of testosterone enanthate on serum lipoproteins in man. Anderson RA; Wallace EM; Wu FC Contraception; 1995 Aug; 52(2):115-9. PubMed ID: 8536448 [TBL] [Abstract][Full Text] [Related]
6. A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. Bhasin S; Swerdloff RS; Steiner B; Peterson MA; Meridores T; Galmirini M; Pandian MR; Goldberg R; Berman N J Clin Endocrinol Metab; 1992 Jan; 74(1):75-83. PubMed ID: 1727832 [TBL] [Abstract][Full Text] [Related]
7. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Whitsel EA; Boyko EJ; Matsumoto AM; Anawalt BD; Siscovick DS Am J Med; 2001 Sep; 111(4):261-9. PubMed ID: 11566455 [TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ J Androl; 1998; 19(6):761-8. PubMed ID: 9876028 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study. Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600 [TBL] [Abstract][Full Text] [Related]
10. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins. Tan KC; Shiu SW; Pang RW; Kung AW Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231 [TBL] [Abstract][Full Text] [Related]
11. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. Haffner SM; Mykkänen L; Valdez RA; Katz MS J Clin Endocrinol Metab; 1993 Dec; 77(6):1610-5. PubMed ID: 8263149 [TBL] [Abstract][Full Text] [Related]
12. Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels. Kenny AM; Prestwood KM; Raisz LG Endocr Res; 2000 May; 26(2):153-68. PubMed ID: 10921445 [TBL] [Abstract][Full Text] [Related]
13. Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men. Sulcová J; Hill M; Masek Z; Ceska R; Novácek A; Hampl R; Stárka L Physiol Res; 2001; 50(1):9-18. PubMed ID: 11300231 [TBL] [Abstract][Full Text] [Related]
14. Hypogonadism and androgen replacement therapy in elderly men. Basaria S; Dobs AS Am J Med; 2001 May; 110(7):563-72. PubMed ID: 11343670 [TBL] [Abstract][Full Text] [Related]
15. HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism. Bolu E; Sonmez A; Tapan S; Taslipinar A; Aydogdu A; Meric C; Basaran Y; Uckaya G; Serdar M; Kurt I; Azal O Horm Metab Res; 2013 Jun; 45(6):443-8. PubMed ID: 23613012 [TBL] [Abstract][Full Text] [Related]
16. Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men. Duschek EJ; Gooren LJ; Netelenbos C Eur J Endocrinol; 2004 Apr; 150(4):539-46. PubMed ID: 15080785 [TBL] [Abstract][Full Text] [Related]
18. Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels. Bagatell CJ; Knopp RH; Vale WW; Rivier JE; Bremner WJ Ann Intern Med; 1992 Jun; 116(12 Pt 1):967-73. PubMed ID: 1586105 [TBL] [Abstract][Full Text] [Related]
19. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group. Winters SJ; Atkinson L Clin Endocrinol (Oxf); 1997 Sep; 47(3):317-22. PubMed ID: 9373453 [TBL] [Abstract][Full Text] [Related]
20. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism. Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]